Surgical Treatment of Moderate Ischemic Mitral Regurgitation

This trial compared coronary-artery bypass grafting alone with CABG plus mitral-valve repair in patients with coronary artery disease and moderate ischemic mitral regurgitation. Mitral-valve repair provided no apparent benefit and was associated with more neurologic complications. Each year, approxi...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 371; no. 23; pp. 2178 - 2188
Main Authors Smith, Peter K, Puskas, John D, Ascheim, Deborah D, Voisine, Pierre, Gelijns, Annetine C, Moskowitz, Alan J, Hung, Judy W, Parides, Michael K, Ailawadi, Gorav, Perrault, Louis P, Acker, Michael A, Argenziano, Michael, Thourani, Vinod, Gammie, James S, Miller, Marissa A, Pagé, Pierre, Overbey, Jessica R, Bagiella, Emilia, Dagenais, François, Blackstone, Eugene H, Kron, Irving L, Goldstein, Daniel J, Rose, Eric A, Moquete, Ellen G, Jeffries, Neal, Gardner, Timothy J, O'Gara, Patrick T, Alexander, John H, Michler, Robert E
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 04.12.2014
Subjects
Online AccessGet full text
ISSN0028-4793
1533-4406
1533-4406
DOI10.1056/NEJMoa1410490

Cover

Abstract This trial compared coronary-artery bypass grafting alone with CABG plus mitral-valve repair in patients with coronary artery disease and moderate ischemic mitral regurgitation. Mitral-valve repair provided no apparent benefit and was associated with more neurologic complications. Each year, approximately 1 million Americans have a myocardial infarction, and nearly 8 million Americans have a history of myocardial infarction. 1 Ischemic mitral regurgitation, which results from functional-valve incompetence due to myocardial injury and adverse left ventricular remodeling, develops in approximately 50% of patients after an infarction, and moderate regurgitation occurs in more than 10% of patients. 2 – 4 Ischemic mitral regurgitation is associated with excess mortality regardless of management. 5 , 6 The valve leaflets and chordal structures in affected patients are “innocent bystanders”; mitral regurgitation results from papillary muscle displacement, leaflet tethering, reduced closing forces, and annular dilatation. 7 – 10 Many patients . . .
AbstractList BackgroundIschemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral-valve repair to coronary-artery bypass grafting (CABG) are uncertain.MethodsWe randomly assigned 301 patients with moderate ischemic mitral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure). The primary end point was the left ventricular end-systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year. This end point was assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized as the lowest LVESVI rank.ResultsAt 1 year, the mean LVESVI among surviving patients was 46.1±22.4 ml per square meter of body-surface area in the CABG-alone group and 49.6±31.5 ml per square meter in the combined-procedure group (mean change from baseline, −9.4 and −9.3 ml per square meter, respectively). The rate of death was 6.7% in the combined-procedure group and 7.3% in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38 to 2.12; P=0.81). The rank-based assessment of LVESVI at 1 year (incorporating deaths) showed no significant between-group difference (z score, 0.50; P=0.61). The addition of mitral-valve repair was associated with a longer bypass time (P<0.001), a longer hospital stay after surgery (P=0.002), and more neurologic events (P=0.03). Moderate or severe mitral regurgitation was less common in the combined-procedure group than in the CABG-alone group (11.2% vs. 31.0%, P<0.001). There were no significant between-group differences in major adverse cardiac or cerebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year.ConclusionsIn patients with moderate ischemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher degree of left ventricular reverse remodeling. Mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation but an increased number of untoward events. Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.)
Ischemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral-valve repair to coronary-artery bypass grafting (CABG) are uncertain. We randomly assigned 301 patients with moderate ischemic mitral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure). The primary end point was the left ventricular end-systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year. This end point was assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized as the lowest LVESVI rank. At 1 year, the mean LVESVI among surviving patients was 46.1±22.4 ml per square meter of body-surface area in the CABG-alone group and 49.6±31.5 ml per square meter in the combined-procedure group (mean change from baseline, -9.4 and -9.3 ml per square meter, respectively). The rate of death was 6.7% in the combined-procedure group and 7.3% in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38 to 2.12; P=0.81). The rank-based assessment of LVESVI at 1 year (incorporating deaths) showed no significant between-group difference (z score, 0.50; P=0.61). The addition of mitral-valve repair was associated with a longer bypass time (P<0.001), a longer hospital stay after surgery (P=0.002), and more neurologic events (P=0.03). Moderate or severe mitral regurgitation was less common in the combined-procedure group than in the CABG-alone group (11.2% vs. 31.0%, P<0.001). There were no significant between-group differences in major adverse cardiac or cerebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year. In patients with moderate ischemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher degree of left ventricular reverse remodeling. Mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation but an increased number of untoward events. Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.).
Ischemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral-valve repair to coronary-artery bypass grafting (CABG) are uncertain.BACKGROUNDIschemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral-valve repair to coronary-artery bypass grafting (CABG) are uncertain.We randomly assigned 301 patients with moderate ischemic mitral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure). The primary end point was the left ventricular end-systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year. This end point was assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized as the lowest LVESVI rank.METHODSWe randomly assigned 301 patients with moderate ischemic mitral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure). The primary end point was the left ventricular end-systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year. This end point was assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized as the lowest LVESVI rank.At 1 year, the mean LVESVI among surviving patients was 46.1±22.4 ml per square meter of body-surface area in the CABG-alone group and 49.6±31.5 ml per square meter in the combined-procedure group (mean change from baseline, -9.4 and -9.3 ml per square meter, respectively). The rate of death was 6.7% in the combined-procedure group and 7.3% in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38 to 2.12; P=0.81). The rank-based assessment of LVESVI at 1 year (incorporating deaths) showed no significant between-group difference (z score, 0.50; P=0.61). The addition of mitral-valve repair was associated with a longer bypass time (P<0.001), a longer hospital stay after surgery (P=0.002), and more neurologic events (P=0.03). Moderate or severe mitral regurgitation was less common in the combined-procedure group than in the CABG-alone group (11.2% vs. 31.0%, P<0.001). There were no significant between-group differences in major adverse cardiac or cerebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year.RESULTSAt 1 year, the mean LVESVI among surviving patients was 46.1±22.4 ml per square meter of body-surface area in the CABG-alone group and 49.6±31.5 ml per square meter in the combined-procedure group (mean change from baseline, -9.4 and -9.3 ml per square meter, respectively). The rate of death was 6.7% in the combined-procedure group and 7.3% in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38 to 2.12; P=0.81). The rank-based assessment of LVESVI at 1 year (incorporating deaths) showed no significant between-group difference (z score, 0.50; P=0.61). The addition of mitral-valve repair was associated with a longer bypass time (P<0.001), a longer hospital stay after surgery (P=0.002), and more neurologic events (P=0.03). Moderate or severe mitral regurgitation was less common in the combined-procedure group than in the CABG-alone group (11.2% vs. 31.0%, P<0.001). There were no significant between-group differences in major adverse cardiac or cerebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year.In patients with moderate ischemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher degree of left ventricular reverse remodeling. Mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation but an increased number of untoward events. Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.).CONCLUSIONSIn patients with moderate ischemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher degree of left ventricular reverse remodeling. Mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation but an increased number of untoward events. Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.).
This trial compared coronary-artery bypass grafting alone with CABG plus mitral-valve repair in patients with coronary artery disease and moderate ischemic mitral regurgitation. Mitral-valve repair provided no apparent benefit and was associated with more neurologic complications. Each year, approximately 1 million Americans have a myocardial infarction, and nearly 8 million Americans have a history of myocardial infarction. 1 Ischemic mitral regurgitation, which results from functional-valve incompetence due to myocardial injury and adverse left ventricular remodeling, develops in approximately 50% of patients after an infarction, and moderate regurgitation occurs in more than 10% of patients. 2 – 4 Ischemic mitral regurgitation is associated with excess mortality regardless of management. 5 , 6 The valve leaflets and chordal structures in affected patients are “innocent bystanders”; mitral regurgitation results from papillary muscle displacement, leaflet tethering, reduced closing forces, and annular dilatation. 7 – 10 Many patients . . .
Author Argenziano, Michael
Acker, Michael A
Puskas, John D
Parides, Michael K
Goldstein, Daniel J
Alexander, John H
Bagiella, Emilia
Jeffries, Neal
O'Gara, Patrick T
Rose, Eric A
Voisine, Pierre
Overbey, Jessica R
Pagé, Pierre
Ailawadi, Gorav
Dagenais, François
Thourani, Vinod
Ascheim, Deborah D
Gelijns, Annetine C
Hung, Judy W
Perrault, Louis P
Kron, Irving L
Miller, Marissa A
Michler, Robert E
Smith, Peter K
Gammie, James S
Moquete, Ellen G
Blackstone, Eugene H
Moskowitz, Alan J
Gardner, Timothy J
Author_xml – sequence: 1
  givenname: Peter K
  surname: Smith
  fullname: Smith, Peter K
  organization: The authors' affiliations are listed in the Appendix
– sequence: 2
  givenname: John D
  surname: Puskas
  fullname: Puskas, John D
  organization: The authors' affiliations are listed in the Appendix
– sequence: 3
  givenname: Deborah D
  surname: Ascheim
  fullname: Ascheim, Deborah D
  organization: The authors' affiliations are listed in the Appendix
– sequence: 4
  givenname: Pierre
  surname: Voisine
  fullname: Voisine, Pierre
  organization: The authors' affiliations are listed in the Appendix
– sequence: 5
  givenname: Annetine C
  surname: Gelijns
  fullname: Gelijns, Annetine C
  organization: The authors' affiliations are listed in the Appendix
– sequence: 6
  givenname: Alan J
  surname: Moskowitz
  fullname: Moskowitz, Alan J
  organization: The authors' affiliations are listed in the Appendix
– sequence: 7
  givenname: Judy W
  surname: Hung
  fullname: Hung, Judy W
  organization: The authors' affiliations are listed in the Appendix
– sequence: 8
  givenname: Michael K
  surname: Parides
  fullname: Parides, Michael K
  organization: The authors' affiliations are listed in the Appendix
– sequence: 9
  givenname: Gorav
  surname: Ailawadi
  fullname: Ailawadi, Gorav
  organization: The authors' affiliations are listed in the Appendix
– sequence: 10
  givenname: Louis P
  surname: Perrault
  fullname: Perrault, Louis P
  organization: The authors' affiliations are listed in the Appendix
– sequence: 11
  givenname: Michael A
  surname: Acker
  fullname: Acker, Michael A
  organization: The authors' affiliations are listed in the Appendix
– sequence: 12
  givenname: Michael
  surname: Argenziano
  fullname: Argenziano, Michael
  organization: The authors' affiliations are listed in the Appendix
– sequence: 13
  givenname: Vinod
  surname: Thourani
  fullname: Thourani, Vinod
  organization: The authors' affiliations are listed in the Appendix
– sequence: 14
  givenname: James S
  surname: Gammie
  fullname: Gammie, James S
  organization: The authors' affiliations are listed in the Appendix
– sequence: 15
  givenname: Marissa A
  surname: Miller
  fullname: Miller, Marissa A
  organization: The authors' affiliations are listed in the Appendix
– sequence: 16
  givenname: Pierre
  surname: Pagé
  fullname: Pagé, Pierre
  organization: The authors' affiliations are listed in the Appendix
– sequence: 17
  givenname: Jessica R
  surname: Overbey
  fullname: Overbey, Jessica R
  organization: The authors' affiliations are listed in the Appendix
– sequence: 18
  givenname: Emilia
  surname: Bagiella
  fullname: Bagiella, Emilia
  organization: The authors' affiliations are listed in the Appendix
– sequence: 19
  givenname: François
  surname: Dagenais
  fullname: Dagenais, François
  organization: The authors' affiliations are listed in the Appendix
– sequence: 20
  givenname: Eugene H
  surname: Blackstone
  fullname: Blackstone, Eugene H
  organization: The authors' affiliations are listed in the Appendix
– sequence: 21
  givenname: Irving L
  surname: Kron
  fullname: Kron, Irving L
  organization: The authors' affiliations are listed in the Appendix
– sequence: 22
  givenname: Daniel J
  surname: Goldstein
  fullname: Goldstein, Daniel J
  organization: The authors' affiliations are listed in the Appendix
– sequence: 23
  givenname: Eric A
  surname: Rose
  fullname: Rose, Eric A
  organization: The authors' affiliations are listed in the Appendix
– sequence: 24
  givenname: Ellen G
  surname: Moquete
  fullname: Moquete, Ellen G
  organization: The authors' affiliations are listed in the Appendix
– sequence: 25
  givenname: Neal
  surname: Jeffries
  fullname: Jeffries, Neal
  organization: The authors' affiliations are listed in the Appendix
– sequence: 26
  givenname: Timothy J
  surname: Gardner
  fullname: Gardner, Timothy J
  organization: The authors' affiliations are listed in the Appendix
– sequence: 27
  givenname: Patrick T
  surname: O'Gara
  fullname: O'Gara, Patrick T
  organization: The authors' affiliations are listed in the Appendix
– sequence: 28
  givenname: John H
  surname: Alexander
  fullname: Alexander, John H
  organization: The authors' affiliations are listed in the Appendix
– sequence: 29
  givenname: Robert E
  surname: Michler
  fullname: Michler, Robert E
  organization: The authors' affiliations are listed in the Appendix
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28938188$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/25405390$$D View this record in MEDLINE/PubMed
BookMark eNp1kdFrFDEQh4O02Gvro6-yIEJftiY7ySYLIkip2tKzoPU55LKz1xy7SU12Bf_75uy22kLzkkC--fHNzD7Z8cEjIa8ZPWZU1O-_nZ4vg2GcUd7QF2TBBEDJOa13yILSSpVcNrBH9lPa0HwYb16SvUpwKqChC_LhxxTXzpq-uIpoxgH9WISuWIYWoxmxOEv2Ggdni6UbY6a-43pbMJrRBX9IdjvTJ3w13wfk5-fTq5Ov5cXll7OTTxel5VKMJROrVc2ZMrXpJAXMVpJZqZiUFVYNr2ClWqYstBVY4DXkpwE0ouHKStbCAfl4l3szrQZsbZbMLvomusHEPzoYpx__eHet1-G35kBBSJkDjuaAGH5NmEY9uGSx743HMCXNauCVos1f9O0TdBOm6HN7W4oKDlWtMvXmf6MHlfvBZuDdDJiUp9tF461L_zjVgGJqG1TecTaGlCJ2Dwijertg_WjBmYcnvJ2XkRt3_bNVs80wJO1xMzzD3QLLM7Ik
CODEN NEJMAG
CitedBy_id crossref_primary_10_1053_j_jvca_2017_06_022
crossref_primary_10_33590_emjcardiol_10310014
crossref_primary_10_1016_j_jtcvs_2019_06_109
crossref_primary_10_1016_S1636_5410_17_86032_3
crossref_primary_10_29001_2073_8552_2024_39_2_46_57
crossref_primary_10_1016_j_jtcvs_2020_10_105
crossref_primary_10_1536_ihj_19_054
crossref_primary_10_1007_s11886_017_0883_5
crossref_primary_10_1016_j_ijcard_2019_05_015
crossref_primary_10_1007_s12928_022_00898_4
crossref_primary_10_1016_j_athoracsur_2020_03_003
crossref_primary_10_12688_f1000research_16066_1
crossref_primary_10_1016_j_jtcvs_2019_01_082
crossref_primary_10_1161_JAHA_117_007596
crossref_primary_10_1016_j_ijcard_2019_02_045
crossref_primary_10_1016_j_suc_2017_04_003
crossref_primary_10_1136_heartjnl_2019_316157
crossref_primary_10_1016_j_jtcvs_2019_07_038
crossref_primary_10_1080_24748706_2017_1326648
crossref_primary_10_1161_JAHA_120_016086
crossref_primary_10_1093_eurheartj_ehv355
crossref_primary_10_1007_s00380_021_01771_9
crossref_primary_10_1016_j_jacc_2014_10_070
crossref_primary_10_1111_jocs_16968
crossref_primary_10_1007_s11883_015_0549_y
crossref_primary_10_1016_j_jtcvs_2021_05_047
crossref_primary_10_17116_kardio202316041411
crossref_primary_10_1016_j_jescts_2018_03_003
crossref_primary_10_1016_j_xjon_2019_12_004
crossref_primary_10_1016_j_athoracsur_2024_03_016
crossref_primary_10_1093_ehjci_jeab023
crossref_primary_10_1530_ERP_16_0019
crossref_primary_10_1007_s11936_020_00841_x
crossref_primary_10_1016_j_cjca_2022_01_017
crossref_primary_10_1080_13696998_2019_1621325
crossref_primary_10_1093_ejcts_ezv478
crossref_primary_10_1007_s00059_019_04847_5
crossref_primary_10_1016_j_jtcvs_2021_04_002
crossref_primary_10_1161_CIRCULATIONAHA_114_014932
crossref_primary_10_1016_j_athoracsur_2016_10_026
crossref_primary_10_1016_j_recesp_2014_12_008
crossref_primary_10_1016_j_jtcvs_2017_11_006
crossref_primary_10_1053_j_semtcvs_2015_10_009
crossref_primary_10_1093_eurheartj_ehv343
crossref_primary_10_1161_CIRCOUTCOMES_117_004466
crossref_primary_10_1097_MAT_0000000000001162
crossref_primary_10_1053_j_jvca_2015_09_012
crossref_primary_10_1111_jocs_15771
crossref_primary_10_1053_j_jvca_2017_06_041
crossref_primary_10_1136_heartjnl_2017_312002
crossref_primary_10_1016_j_athoracsur_2015_10_083
crossref_primary_10_1016_j_cjca_2023_11_031
crossref_primary_10_1016_j_jcin_2016_07_005
crossref_primary_10_31083_j_rcm2411328
crossref_primary_10_1161_CIRCIMAGING_120_011608
crossref_primary_10_1080_21645515_2018_1508624
crossref_primary_10_1161_CIRCULATIONAHA_116_025260
crossref_primary_10_1056_NEJMra1406944
crossref_primary_10_1016_j_athoracsur_2021_09_001
crossref_primary_10_1016_j_jtcvs_2017_03_039
crossref_primary_10_1016_j_jtcvs_2022_04_049
crossref_primary_10_1016_j_ahj_2018_07_021
crossref_primary_10_1161_CIR_0000000000000659
crossref_primary_10_1136_heartjnl_2021_319045
crossref_primary_10_1177_1089253214568531
crossref_primary_10_1097_HCO_0000000000000325
crossref_primary_10_1002_14651858_CD015777
crossref_primary_10_1016_j_ahj_2015_04_010
crossref_primary_10_1536_ihj_20_712
crossref_primary_10_1093_eurheartj_ehab540
crossref_primary_10_1016_j_jtcvs_2020_02_132
crossref_primary_10_1080_16878507_2019_1594129
crossref_primary_10_1038_s41569_023_00911_0
crossref_primary_10_1016_j_jsha_2019_06_004
crossref_primary_10_1093_eurheartj_ehv123
crossref_primary_10_3390_jcm10214816
crossref_primary_10_1056_NEJMoa1602003
crossref_primary_10_1053_j_jvca_2017_02_046
crossref_primary_10_1136_heartjnl_2015_307473
crossref_primary_10_1016_S1634_7358_17_86075_7
crossref_primary_10_1002_ccd_26431
crossref_primary_10_1161_CIRCULATIONAHA_118_037077
crossref_primary_10_1136_openhrt_2020_001339
crossref_primary_10_1161_CIR_0000000000000503
crossref_primary_10_1007_s00059_016_4444_2
crossref_primary_10_1016_j_cardfail_2018_01_010
crossref_primary_10_1007_s11748_019_01212_5
crossref_primary_10_1007_s00392_015_0914_4
crossref_primary_10_1016_j_jscai_2023_101032
crossref_primary_10_1007_s11936_019_0799_z
crossref_primary_10_1093_eurheartj_ehv719
crossref_primary_10_1056_NEJMe1412045
crossref_primary_10_1053_j_jvca_2021_05_040
crossref_primary_10_1093_ejcts_ezy024
crossref_primary_10_1002_ejhf_1634
crossref_primary_10_1111_jocs_12602
crossref_primary_10_1016_j_jacc_2019_09_017
crossref_primary_10_3389_fcvm_2022_1002768
crossref_primary_10_1080_00952990_2019_1634086
crossref_primary_10_1016_j_ijcard_2018_06_004
crossref_primary_10_1007_s10439_018_02122_y
crossref_primary_10_1016_j_jtcvs_2017_03_101
crossref_primary_10_1016_j_jacc_2020_11_018
crossref_primary_10_1002_ejhf_592
crossref_primary_10_1161_CIR_0000000000000757
crossref_primary_10_1016_j_carrev_2019_04_025
crossref_primary_10_1080_23312025_2019_1619219
crossref_primary_10_1536_ihj_18_613
crossref_primary_10_1016_j_jtcvs_2015_09_122
crossref_primary_10_1093_ejcts_ezz238
crossref_primary_10_1177_1089253217745363
crossref_primary_10_1177_0267659118811045
crossref_primary_10_1002_cnm_2858
crossref_primary_10_2169_naika_105_222
crossref_primary_10_1161_CIR_0000000000001052
crossref_primary_10_1016_j_amjcard_2016_11_024
crossref_primary_10_1016_j_pcad_2021_11_005
crossref_primary_10_1186_s13019_016_0536_6
crossref_primary_10_1016_j_jtcvs_2018_09_018
crossref_primary_10_4244_EIJY19M01_01
crossref_primary_10_1097_MCA_0000000000000271
crossref_primary_10_1016_j_ahj_2018_05_001
crossref_primary_10_1007_s11748_022_01822_6
crossref_primary_10_1016_j_jacc_2015_02_009
crossref_primary_10_1186_s12872_017_0577_3
crossref_primary_10_3389_fcvm_2021_675722
crossref_primary_10_1016_j_shj_2022_100129
crossref_primary_10_1111_jocs_14487
crossref_primary_10_1016_j_jtcvs_2017_08_016
crossref_primary_10_1016_j_jcmg_2021_05_017
crossref_primary_10_1097_HCO_0000000000000414
crossref_primary_10_1016_j_athoracsur_2021_03_106
crossref_primary_10_1080_24748706_2020_1777359
crossref_primary_10_1007_s11748_023_01925_8
crossref_primary_10_1177_1556984519890602
crossref_primary_10_1002_ejhf_1612
crossref_primary_10_1111_jocs_14924
crossref_primary_10_1161_CIRCIMAGING_122_015134
crossref_primary_10_1016_j_recesp_2019_06_005
crossref_primary_10_1016_j_hrthm_2015_02_022
crossref_primary_10_2459_JCM_0000000000000658
crossref_primary_10_1080_14017431_2016_1248482
crossref_primary_10_1016_j_vph_2023_107274
crossref_primary_10_1007_s12055_016_0472_z
crossref_primary_10_1093_ejcts_ezy289
crossref_primary_10_1016_j_jacc_2019_04_002
crossref_primary_10_1016_j_athoracsur_2021_09_037
crossref_primary_10_1016_j_jcmg_2020_10_027
crossref_primary_10_1093_eurheartj_ehw128
crossref_primary_10_1016_j_carrev_2019_04_008
crossref_primary_10_1016_j_hlc_2020_08_015
crossref_primary_10_1080_15384047_2019_1598760
crossref_primary_10_1053_j_semtcvs_2023_04_003
crossref_primary_10_1093_ejcts_ezy174
crossref_primary_10_1016_j_jcmg_2016_12_003
crossref_primary_10_1016_j_jacc_2017_07_751
crossref_primary_10_1016_j_jcmg_2021_11_005
crossref_primary_10_1016_j_rec_2019_08_003
crossref_primary_10_1007_s12055_017_0511_4
crossref_primary_10_1517_14712598_2016_1164688
crossref_primary_10_1016_j_jcmg_2018_11_006
crossref_primary_10_1093_ehjci_jey023
crossref_primary_10_1080_24748706_2019_1610201
crossref_primary_10_21320_1818_474X_2021_4_88_97
crossref_primary_10_3390_biomedicines9050447
crossref_primary_10_1016_j_jtcvs_2015_09_034
crossref_primary_10_1093_ejcts_ezw155
crossref_primary_10_4236_wjcs_2022_126011
crossref_primary_10_1016_j_jtcvs_2015_02_047
crossref_primary_10_1016_j_jacc_2021_04_099
crossref_primary_10_1002_ejhf_3573
crossref_primary_10_2147_VHRM_S479352
crossref_primary_10_1053_j_jvca_2015_08_022
crossref_primary_10_1007_s00059_015_4382_4
crossref_primary_10_1007_s12471_020_01412_2
crossref_primary_10_3390_ijerph192114400
crossref_primary_10_1053_j_jvca_2016_06_032
crossref_primary_10_1007_s11886_016_0808_8
crossref_primary_10_1161_CIRCINTERVENTIONS_121_010628
crossref_primary_10_1016_j_cpcardiol_2020_100679
crossref_primary_10_1111_jocs_14011
crossref_primary_10_1016_j_jtcvs_2020_12_125
crossref_primary_10_1080_15287394_2019_1640816
crossref_primary_10_1161_CIR_0000000000000950
crossref_primary_10_1016_j_jtcvs_2015_08_127
crossref_primary_10_1161_CIR_0000000000001123
crossref_primary_10_1177_02676591221144558
crossref_primary_10_1016_j_crvasa_2017_01_017
crossref_primary_10_1007_s12055_019_00811_4
crossref_primary_10_1016_j_circv_2015_08_004
crossref_primary_10_1016_j_jacc_2020_12_012
crossref_primary_10_1002_ehf2_12287
crossref_primary_10_1253_circj_CJ_20_1282
crossref_primary_10_1016_j_carrev_2020_05_015
crossref_primary_10_1111_jocs_13722
crossref_primary_10_1161_CIR_0000000000000923
crossref_primary_10_1016_j_jtcvs_2020_02_084
crossref_primary_10_1080_14017431_2017_1405068
crossref_primary_10_1007_s12055_018_0717_0
crossref_primary_10_1016_j_amjmed_2018_01_048
crossref_primary_10_1016_j_jtcvs_2019_06_040
crossref_primary_10_1016_j_athoracsur_2015_06_057
crossref_primary_10_1016_j_recesp_2016_02_024
crossref_primary_10_1177_0267659117693683
crossref_primary_10_1186_s13019_022_01993_6
crossref_primary_10_1053_j_semtcvs_2022_03_002
crossref_primary_10_1016_j_athoracsur_2015_11_035
crossref_primary_10_1161_CIRCULATIONAHA_117_026957
crossref_primary_10_1016_j_amjcard_2016_10_049
crossref_primary_10_1016_j_jtcvs_2020_06_070
crossref_primary_10_26442_00403660_2020_05_000697
crossref_primary_10_1161_JAHA_122_026943
crossref_primary_10_1016_j_jacc_2014_10_016
crossref_primary_10_1016_j_crvasa_2015_09_006
crossref_primary_10_1080_24748706_2020_1753899
crossref_primary_10_1253_circj_CJ_14_1329
crossref_primary_10_1161_CIRCIMAGING_116_005451
crossref_primary_10_4244_AIJ_D_19_00036
crossref_primary_10_1161_JAHA_117_007163
crossref_primary_10_1016_j_ijcard_2015_11_137
crossref_primary_10_1097_CRD_0000000000000061
crossref_primary_10_1002_ejhf_2458
crossref_primary_10_1016_j_rec_2016_04_003
crossref_primary_10_1016_j_acvd_2018_09_006
crossref_primary_10_1016_j_hfc_2018_06_006
crossref_primary_10_1053_j_jvca_2016_10_009
crossref_primary_10_1016_j_repce_2015_04_005
crossref_primary_10_1093_eurheartj_ehy394
crossref_primary_10_1016_j_jtcvs_2018_05_060
crossref_primary_10_1016_j_athoracsur_2021_03_043
crossref_primary_10_5761_atcs_oa_20_00035
crossref_primary_10_1097_HCO_0000000000000270
crossref_primary_10_36290_kar_2019_025
crossref_primary_10_1016_j_circv_2016_11_060
crossref_primary_10_1093_eurheartj_ehy158
crossref_primary_10_1093_ejcts_ezy410
crossref_primary_10_1016_j_repc_2015_03_002
crossref_primary_10_4330_wjc_v10_i10_141
crossref_primary_10_1177_1089253216687858
crossref_primary_10_1080_17487870_2018_1509712
crossref_primary_10_1002_ejhf_1598
crossref_primary_10_1016_j_jtcvs_2017_03_066
crossref_primary_10_1016_j_jtcvs_2018_05_073
crossref_primary_10_1097_HCO_0000000000000262
crossref_primary_10_1097_JS9_0000000000001277
crossref_primary_10_14789_jmj_JMJ22_0021_OA
crossref_primary_10_1038_nrcardio_2015_161
crossref_primary_10_1016_j_jcmg_2022_05_004
crossref_primary_10_1016_j_hlc_2021_08_013
crossref_primary_10_1097_HCO_0000000000000146
crossref_primary_10_1016_j_jtcvs_2019_06_094
crossref_primary_10_1186_s44156_023_00015_y
crossref_primary_10_1161_CIRCULATIONAHA_114_013125
crossref_primary_10_7793_jcoron_jcoron_21_011
crossref_primary_10_1097_CRD_0000000000000361
crossref_primary_10_1136_openhrt_2017_000745
crossref_primary_10_1016_j_athoracsur_2015_07_045
crossref_primary_10_1016_j_jtcvs_2017_01_031
crossref_primary_10_1016_j_jtcvs_2022_09_035
crossref_primary_10_1016_S0140_6736_15_61220_X
crossref_primary_10_1038_s41569_020_0395_7
crossref_primary_10_1056_NEJMe2411217
crossref_primary_10_1097_HCO_0000000000000495
crossref_primary_10_17816_CS601825
crossref_primary_10_1111_jocs_12585
crossref_primary_10_7759_cureus_37238
crossref_primary_10_1186_s12871_016_0271_5
crossref_primary_10_23736_S0021_9509_24_12851_0
crossref_primary_10_1016_j_jacc_2020_11_066
crossref_primary_10_1016_j_jtcvs_2015_09_094
crossref_primary_10_1007_s10554_018_1509_8
crossref_primary_10_1093_ejcts_ezw022
crossref_primary_10_1093_eurheartj_ehaa707
crossref_primary_10_33290_jtvt_ra_24_0008
crossref_primary_10_1161_CIRCULATIONAHA_115_021014
crossref_primary_10_5339_gcsp_2015_30
crossref_primary_10_1056_NEJMc1503128
crossref_primary_10_1093_ehjqcco_qcv024
crossref_primary_10_1093_icvts_ivac163
crossref_primary_10_1016_j_circv_2022_09_011
crossref_primary_10_1080_17460441_2016_1237939
crossref_primary_10_1253_circj_CJ_16_1280
crossref_primary_10_1016_j_jchf_2019_03_001
crossref_primary_10_1053_j_jvca_2018_07_043
crossref_primary_10_18087_cardio_2019_5_2607
crossref_primary_10_1093_eurheartj_suw028
crossref_primary_10_1016_j_jacc_2015_11_036
crossref_primary_10_1097_HCO_0000000000000916
crossref_primary_10_1177_1089253218792921
crossref_primary_10_1093_eurheartj_ehv687
crossref_primary_10_1016_j_jacc_2017_03_011
crossref_primary_10_1016_j_ccl_2017_08_006
Cites_doi 10.1161/CIRCULATIONAHA.112.143818
10.1161/01.CIR.96.3.827
10.1016/j.jtcvs.2012.09.007
10.1016/j.jtcvs.2003.09.010
10.1161/CIRCULATIONAHA.108.842104
10.1161/CIRCULATIONAHA.111.072256
10.1161/01.cir.0000441139.02102.80
10.1056/NEJMoa0906431
10.1161/CIRCULATIONAHA.113.005223
10.1016/j.athoracsur.2008.05.017
10.1016/j.jtcvs.2008.11.010
10.1161/01.CIR.76.1.44
10.1093/eurheartj/ehm469
10.1016/0735-1097(92)90455-V
10.1016/j.jacc.2014.02.536
10.1161/01.CIR.76.4.777
10.1161/CIRCULATIONAHA.104.523472
10.1016/j.jtcvs.2008.12.023
10.1016/j.jacc.2011.08.009
10.1016/j.athoracsur.2010.03.103
10.1016/j.athoracsur.2010.11.009
10.1054/jcaf.2003.22
10.1111/j.1540-8175.2006.00163.x
10.1016/j.athoracsur.2004.07.040
10.1161/01.CIR.0000151097.30779.04
10.1016/j.jtcvs.2011.05.006
10.1016/j.athoracsur.2004.11.005
10.1016/j.jtcvs.2011.10.029
10.1016/S1010-7940(01)00770-9
10.1161/01.CIR.0000138196.06772.4e
10.1067/mtc.2003.78
10.2307/2336502
10.1054/j.cardfail.2003.09.001
10.1016/S0894-7317(03)00335-3
10.1016/j.athoracsur.2005.03.034
10.1161/01.CIR.102.12.1400
10.1161/hc37t1.094706
10.1016/j.jacc.2004.10.030
10.2307/2530245
10.1161/CIRCULATIONAHA.105.000398
ContentType Journal Article
Contributor Argenziano, Michael
Ferguson, T Bruce
Ralph, Jennifer
Van Patten, Danielle
Ye, Xia
Noiseux, Nicolas
Berry, Mark F
Prieto, Ignacio
Stewart, Allan
Schwartz, Allan
Harrison, J Kevin
Chen, Yingchun
Clarke, Pamela A
Jeffries, Neal O
Chen, Frederick Y
Miller, Marissa A
Gupta, Lopa
Pattakos, Gregory
Santos, Milerva
O'Neal, Allison
Kypson, Alan P
Buxton, Dennis
Sankovic, Kathy
Blackstone, Eugene H
Kirkwood, Katherine
Gombos, Ilana Kogan
Williams, Paula
Smith, Robert L
Davidson, Michael
Weglinski, Michael
Ryan, William
Parides, Michael K
Alexander, John H
Harris, Malissa
Wiggers, Henrik
Couper, Gregory
Smith, Craig R
Welsh, Stacey
Rodriguez, Evelio
Rose, Eric A
Chase, Melissa
Glower, Donald D
Tong, Betty C
Ascheim, Deborah D
Wood, Carrie
Akers, Brenda
Nielsen, Sten Lyager
Whitman, Christine
Sreekanth, Sowmya
Smith, Peter K
Moy, Claudia S
Bolman, 3rd, R Morton
Dolney, Diana
Goldfarb, Seth
Chang, Helena
Adame, Tracine
Aranki, Sary
Berroteran, Leoma
Parsa, Cyrus J
Caulder, Ron
Kumbarce, Edlira
Lackner, Pamela
Geller, Nancy L
Levitan, Ron
Milano, Carmelo A
O'Gar
Contributor_xml – sequence: 1
  givenname: Marissa A
  surname: Miller
  fullname: Miller, Marissa A
– sequence: 2
  givenname: Wendy C
  surname: Taddei-Peters
  fullname: Taddei-Peters, Wendy C
– sequence: 3
  givenname: Dennis
  surname: Buxton
  fullname: Buxton, Dennis
– sequence: 4
  givenname: Ron
  surname: Caulder
  fullname: Caulder, Ron
– sequence: 5
  givenname: Nancy L
  surname: Geller
  fullname: Geller, Nancy L
– sequence: 6
  givenname: David
  surname: Gordon
  fullname: Gordon, David
– sequence: 7
  givenname: Neal O
  surname: Jeffries
  fullname: Jeffries, Neal O
– sequence: 8
  givenname: Albert
  surname: Lee
  fullname: Lee, Albert
– sequence: 9
  givenname: Claudia S
  surname: Moy
  fullname: Moy, Claudia S
– sequence: 10
  givenname: Ilana Kogan
  surname: Gombos
  fullname: Gombos, Ilana Kogan
– sequence: 11
  givenname: Jennifer
  surname: Ralph
  fullname: Ralph, Jennifer
– sequence: 12
  givenname: Richard
  surname: Weisel
  fullname: Weisel, Richard
– sequence: 13
  givenname: Timothy J
  surname: Gardner
  fullname: Gardner, Timothy J
– sequence: 14
  givenname: Patrick T
  surname: O'Gara
  fullname: O'Gara, Patrick T
– sequence: 15
  givenname: Eric A
  surname: Rose
  fullname: Rose, Eric A
– sequence: 16
  givenname: Annetine C
  surname: Gelijns
  fullname: Gelijns, Annetine C
– sequence: 17
  givenname: Michael K
  surname: Parides
  fullname: Parides, Michael K
– sequence: 18
  givenname: Deborah D
  surname: Ascheim
  fullname: Ascheim, Deborah D
– sequence: 19
  givenname: Alan J
  surname: Moskowitz
  fullname: Moskowitz, Alan J
– sequence: 20
  givenname: Ellen
  surname: Moquete
  fullname: Moquete, Ellen
– sequence: 21
  givenname: Helena
  surname: Chang
  fullname: Chang, Helena
– sequence: 22
  givenname: Melissa
  surname: Chase
  fullname: Chase, Melissa
– sequence: 23
  givenname: Yingchun
  surname: Chen
  fullname: Chen, Yingchun
– sequence: 24
  givenname: Seth
  surname: Goldfarb
  fullname: Goldfarb, Seth
– sequence: 25
  givenname: Lopa
  surname: Gupta
  fullname: Gupta, Lopa
– sequence: 26
  givenname: Katherine
  surname: Kirkwood
  fullname: Kirkwood, Katherine
– sequence: 27
  givenname: Edlira
  surname: Kumbarce
  fullname: Kumbarce, Edlira
– sequence: 28
  givenname: Ron
  surname: Levitan
  fullname: Levitan, Ron
– sequence: 29
  givenname: Karen
  surname: O'Sullivan
  fullname: O'Sullivan, Karen
– sequence: 30
  givenname: Jessica
  surname: Overbey
  fullname: Overbey, Jessica
– sequence: 31
  givenname: Milerva
  surname: Santos
  fullname: Santos, Milerva
– sequence: 32
  givenname: Michael
  surname: Weglinski
  fullname: Weglinski, Michael
– sequence: 33
  givenname: Paula
  surname: Williams
  fullname: Williams, Paula
– sequence: 34
  givenname: Carrie
  surname: Wood
  fullname: Wood, Carrie
– sequence: 35
  givenname: Xia
  surname: Ye
  fullname: Ye, Xia
– sequence: 36
  givenname: Sten Lyager
  surname: Nielsen
  fullname: Nielsen, Sten Lyager
– sequence: 37
  givenname: Henrik
  surname: Wiggers
  fullname: Wiggers, Henrik
– sequence: 38
  givenname: Henning
  surname: Malgaard
  fullname: Malgaard, Henning
– sequence: 39
  givenname: Michael
  surname: Mack
  fullname: Mack, Michael
– sequence: 40
  givenname: Tracine
  surname: Adame
  fullname: Adame, Tracine
– sequence: 41
  givenname: Natalie
  surname: Settele
  fullname: Settele, Natalie
– sequence: 42
  givenname: Jenny
  surname: Adams
  fullname: Adams, Jenny
– sequence: 43
  givenname: William
  surname: Ryan
  fullname: Ryan, William
– sequence: 44
  givenname: Robert L
  surname: Smith
  fullname: Smith, Robert L
– sequence: 45
  givenname: Paul
  surname: Grayburn
  fullname: Grayburn, Paul
– sequence: 46
  givenname: Frederick Y
  surname: Chen
  fullname: Chen, Frederick Y
– sequence: 47
  givenname: Anju
  surname: Nohria
  fullname: Nohria, Anju
– sequence: 48
  givenname: Lawrence
  surname: Cohn
  fullname: Cohn, Lawrence
– sequence: 49
  givenname: Prem
  surname: Shekar
  fullname: Shekar, Prem
– sequence: 50
  givenname: Sary
  surname: Aranki
  fullname: Aranki, Sary
– sequence: 51
  givenname: Gregory
  surname: Couper
  fullname: Couper, Gregory
– sequence: 52
  givenname: Michael
  surname: Davidson
  fullname: Davidson, Michael
– sequence: 53
  givenname: R Morton
  surname: Bolman, 3rd
  fullname: Bolman, 3rd, R Morton
– sequence: 54
  givenname: Anne
  surname: Burgess
  fullname: Burgess, Anne
– sequence: 55
  givenname: Debra
  surname: Conboy
  fullname: Conboy, Debra
– sequence: 56
  givenname: Nicolas
  surname: Noiseux
  fullname: Noiseux, Nicolas
– sequence: 57
  givenname: Louis-Mathieu
  surname: Stevens
  fullname: Stevens, Louis-Mathieu
– sequence: 58
  givenname: Ignacio
  surname: Prieto
  fullname: Prieto, Ignacio
– sequence: 59
  givenname: Fadi
  surname: Basile
  fullname: Basile, Fadi
– sequence: 60
  givenname: Joannie
  surname: Dionne
  fullname: Dionne, Joannie
– sequence: 61
  givenname: Julie
  surname: Fecteau
  fullname: Fecteau, Julie
– sequence: 62
  givenname: Eugene H
  surname: Blackstone
  fullname: Blackstone, Eugene H
– sequence: 63
  givenname: A Marc
  surname: Gillinov
  fullname: Gillinov, A Marc
– sequence: 64
  givenname: Pamela
  surname: Lackner
  fullname: Lackner, Pamela
– sequence: 65
  givenname: Leoma
  surname: Berroteran
  fullname: Berroteran, Leoma
– sequence: 66
  givenname: Diana
  surname: Dolney
  fullname: Dolney, Diana
– sequence: 67
  givenname: Suzanne
  surname: Fleming
  fullname: Fleming, Suzanne
– sequence: 68
  givenname: Roberta
  surname: Palumbo
  fullname: Palumbo, Roberta
– sequence: 69
  givenname: Christine
  surname: Whitman
  fullname: Whitman, Christine
– sequence: 70
  givenname: Kathy
  surname: Sankovic
  fullname: Sankovic, Kathy
– sequence: 71
  givenname: Denise Kosty
  surname: Sweeney
  fullname: Sweeney, Denise Kosty
– sequence: 72
  givenname: Gregory
  surname: Pattakos
  fullname: Pattakos, Gregory
– sequence: 73
  givenname: Pamela A
  surname: Clarke
  fullname: Clarke, Pamela A
– sequence: 74
  givenname: Michael
  surname: Argenziano
  fullname: Argenziano, Michael
– sequence: 75
  givenname: Mathew
  surname: Williams
  fullname: Williams, Mathew
– sequence: 76
  givenname: Lyn
  surname: Goldsmith
  fullname: Goldsmith, Lyn
– sequence: 77
  givenname: Craig R
  surname: Smith
  fullname: Smith, Craig R
– sequence: 78
  givenname: Yoshifumi
  surname: Naka
  fullname: Naka, Yoshifumi
– sequence: 79
  givenname: Allan
  surname: Stewart
  fullname: Stewart, Allan
– sequence: 80
  givenname: Allan
  surname: Schwartz
  fullname: Schwartz, Allan
– sequence: 81
  givenname: Daniel
  surname: Bell
  fullname: Bell, Daniel
– sequence: 82
  givenname: Danielle
  surname: Van Patten
  fullname: Van Patten, Danielle
– sequence: 83
  givenname: Sowmya
  surname: Sreekanth
  fullname: Sreekanth, Sowmya
– sequence: 84
  givenname: Peter K
  surname: Smith
  fullname: Smith, Peter K
– sequence: 85
  givenname: John H
  surname: Alexander
  fullname: Alexander, John H
– sequence: 86
  givenname: Carmelo A
  surname: Milano
  fullname: Milano, Carmelo A
– sequence: 87
  givenname: Donald D
  surname: Glower
  fullname: Glower, Donald D
– sequence: 88
  givenname: Joseph P
  surname: Mathew
  fullname: Mathew, Joseph P
– sequence: 89
  givenname: J Kevin
  surname: Harrison
  fullname: Harrison, J Kevin
– sequence: 90
  givenname: Stacey
  surname: Welsh
  fullname: Welsh, Stacey
– sequence: 91
  givenname: Mark F
  surname: Berry
  fullname: Berry, Mark F
– sequence: 92
  givenname: Cyrus J
  surname: Parsa
  fullname: Parsa, Cyrus J
– sequence: 93
  givenname: Betty C
  surname: Tong
  fullname: Tong, Betty C
– sequence: 94
  givenname: Judson B
  surname: Williams
  fullname: Williams, Judson B
– sequence: 95
  givenname: T Bruce
  surname: Ferguson
  fullname: Ferguson, T Bruce
– sequence: 96
  givenname: Alan P
  surname: Kypson
  fullname: Kypson, Alan P
– sequence: 97
  givenname: Evelio
  surname: Rodriguez
  fullname: Rodriguez, Evelio
– sequence: 98
  givenname: Malissa
  surname: Harris
  fullname: Harris, Malissa
– sequence: 99
  givenname: Brenda
  surname: Akers
  fullname: Akers, Brenda
– sequence: 100
  givenname: Allison
  surname: O'Neal
  fullname: O'Neal, Allison
Copyright Copyright © 2014 Massachusetts Medical Society. All rights reserved.
2015 INIST-CNRS
Copyright © 2014 Massachusetts Medical Society. 2014
Copyright_xml – notice: Copyright © 2014 Massachusetts Medical Society. All rights reserved.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2014 Massachusetts Medical Society. 2014
CorporateAuthor Cardiothoracic Surgical Trials Network Investigators
CorporateAuthor_xml – name: Cardiothoracic Surgical Trials Network Investigators
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1056/NEJMoa1410490
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Index
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
New England Journal of Medicine
Biological Sciences
Consumer Health Database
Healthcare Administration Database
Proquest Medical Database
Psychology Database
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-4406
EndPage 2188
ExternalDocumentID PMC4303577
3517214441
25405390
28938188
10_1056_NEJMoa1410490
NJ201412043712307
Genre Original Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations New York
United States--US
GeographicLocations_xml – name: New York
– name: United States--US
GrantInformation_xml – fundername: Canadian Institutes of Health Research
– fundername: NHLBI NIH HHS
  grantid: UM1 HL088955
– fundername: NHLBI NIH HHS
  grantid: U01 HL088942
– fundername: NHLBI NIH HHS
  grantid: UM1 HL088925
– fundername: NCATS NIH HHS
  grantid: UL1 TR000439
– fundername: NHLBI NIH HHS
  grantid: UM1 HL088953
GroupedDBID -
0R
0WA
123
186
1KJ
1VV
29N
2KS
2WC
34G
39C
3V.
4
4.4
53G
55
5D0
5RE
7FN
7RV
7X7
85S
8AO
8C1
8FE
8FH
8FI
AACLI
AAEJM
AAIKC
AAJWC
AALRV
AAPBV
AAQQT
AARDX
AAWTL
ABACO
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQIJ
ABUWG
ABWJO
ACGFS
ACGOD
ACJLH
ACNCT
ACPRK
ACRZS
ADBBV
ADBIT
ADCBC
ADRHT
AENEX
AETEA
AFFNX
AFHKK
AFKRA
AGFXO
AGNAY
AHMBA
AJJEV
AJVPN
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
AZQEC
BBAFP
BBNVY
BCU
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C45
CJ0
CO
CS3
DCD
DU5
DWQXO
DZ
EBS
EJD
ET
EX3
F20
F5P
FD8
FM.
FYUFA
GJ
GNUQQ
GUQSH
H13
HCIFZ
HZ
I4R
IH2
K-O
KM
KOO
L7B
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MVM
N9A
NAPCQ
NEJ
O9-
OK1
OMK
OVD
P-O
P-S
P2P
PADUT
PCD
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QJJ
RHI
RWL
RXW
S10
S6N
SJFOW
SJN
TAE
TAF
TEORI
TN5
TUQ
TWZ
UCV
UKR
UMD
UQL
VQA
W2G
WH7
WOQ
WOW
X
X7M
XJT
XYN
XZL
YCJ
YNT
YRY
YZZ
ZA5
ZHY
ZKB
---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
0R~
1CY
36B
AAMNW
AAQOH
AAYXX
ABBLC
ABCQX
ABDQB
ABJNI
ACKOT
ACPFK
ADUKH
AERZD
AFOSN
AGHSJ
ALIPV
BYPQX
CCPQU
CITATION
HF~
HMCUK
HZ~
N4W
PHGZM
PHGZT
PSYQQ
UKHRP
YFH
YR2
YR5
YYP
ZCA
ZR0
ZVN
~KM
3O-
41~
6TJ
8WZ
9M8
A6W
AAUTI
AAYOK
ABDPE
ABEFU
ACPVT
ACTDY
AFFDN
AJUXI
D0S
FA8
IQODW
J5H
LPU
MQT
NHB
OHT
QZG
SKT
UBX
UIG
WHG
XOL
YHZ
YQI
YQJ
YYQ
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7XB
BEC
K0Y
MBDVC
PKEHL
PUEGO
Q9U
7X8
5PM
ID FETCH-LOGICAL-c475t-15bb6418a6af703e02871c781772e29423b8d18c3d23c34638c3a3ea5948c71d3
IEDL.DBID 8C1
ISSN 0028-4793
1533-4406
IngestDate Thu Aug 21 13:30:30 EDT 2025
Thu Sep 04 22:34:01 EDT 2025
Sat Aug 23 14:30:52 EDT 2025
Mon Jul 21 05:37:46 EDT 2025
Wed Apr 02 07:15:14 EDT 2025
Thu Apr 24 23:08:52 EDT 2025
Tue Jul 01 02:37:08 EDT 2025
Tue Dec 21 14:38:59 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 23
Keywords Medicine
Mitral valve
Treatment
Ischemia
Cardiac valvular disease
Surgery
Mitral regurgitation
Cardiovascular disease
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c475t-15bb6418a6af703e02871c781772e29423b8d18c3d23c34638c3a3ea5948c71d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
The Cardiothoracic Surgical Trials Network investigators are listed in the Supplementary Appendix, available at NEJM.org.
OpenAccessLink https://www.nejm.org/doi/pdf/10.1056/NEJMoa1410490?articleTools=true
PMID 25405390
PQID 1630543268
PQPubID 40644
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4303577
proquest_miscellaneous_1634280977
proquest_journals_1630543268
pubmed_primary_25405390
pascalfrancis_primary_28938188
crossref_primary_10_1056_NEJMoa1410490
crossref_citationtrail_10_1056_NEJMoa1410490
mms_nejm_10_1056_NEJMoa1410490
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-12-04
PublicationDateYYYYMMDD 2014-12-04
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12-04
  day: 04
PublicationDecade 2010
PublicationPlace Waltham, MA
PublicationPlace_xml – name: Waltham, MA
– name: United States
– name: Boston
PublicationTitle The New England journal of medicine
PublicationTitleAlternate N Engl J Med
PublicationYear 2014
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References Hillis, LD, Smith, PK, Anderson, JL (r033) 2011; 58
Penicka, M, Linkova, H, Lang, O (r016) 2009; 120
Kim, YH, Czer, LS, Soukiasian, HJ (r032) 2005; 79
Lam, BK, Gillinov, AM, Blackstone, EH (r011) 2005; 79
Milano, CA, Daneshmand, MA, Rankin, JS (r029) 2008; 86
Yiu, SF, Enriquez-Sarano, M, Tribouilloy, C, Seward, JB, Tajik, AJ (r009) 2000; 102
Lee, R, Li, S, Rankin, JS (r021) 2011; 91
Carson, P, Tognoni, G, Cohn, JN (r040) 2003; 9
Nishimura, RA, Otto, CM, Bonow, RO (r034) 2014; 63
ElBardissi, AW, Aranki, SF, Sheng, S, O'Brien, SM, Greenberg, CC, Gammie, JS (r020) 2012; 143
Bax, JJ, Braun, J, Somer, ST (r019) 2004; 110
Fattouch, K, Guccione, F, Sampognaro, R (r036) 2009; 138
Kono, T, Sabbah, HN, Rosman, H, Alam, M, Jafri, S, Goldstein, S (r008) 1992; 20
Castleberry, AW, Williams, JB, Daneshmand, MA (r005) 2014; 129
Konstam, MA, Udelson, JE, Anand, IS, Cohn, JN (r039) 2003; 9
Deja, MA, Grayburn, PA, Sun, B (r027) 2012; 125
Michler, RE, Rouleau, JL, Al-Khalidi, HR (r035) 2013; 146
Mallidi, HR, Pelletier, MP, Lamb, J (r014) 2004; 127
Lamas, GA, Mitchell, GF, Flaker, GC (r004) 1997; 96
Wong, DR, Agnihotri, AK, Hung, JW (r031) 2005; 80
Perez de Isla, L, Zamorano, J, Quezada, M (r003) 2007; 28
Lan, KKG, DeMets, DL (r025) 1983; 70
Fattouch, K, Sampognaro, R, Speziale, G (r013) 2010; 90
Moss, AJ, Hall, WJ, Cannom, DS (r041) 2009; 361
Bursi, F, Enriquez-Sarano, M, Nkomo, VT (r002) 2005; 111
Chan, KM, Punjabi, PP, Flather, M (r037) 2012; 126
Ryden, T, Bech-Hanssen, O, Brandrup-Wognsen, G, Nilsson, F, Svensson, S, Jeppsson, A (r030) 2001; 20
Smith, PK, Michler, RE, Woo, YJ (r022) 2012; 143
Kumanohoso, T, Otsuji, Y, Yoshifuku, S (r010) 2003; 125
O'Brien, PC, Fleming, TR (r024) 1979; 35
Flynn, M, Curtin, R, Nowicki, ER (r018) 2009; 137
Zoghbi, WA, Enriquez-Sarano, M, Foster, E (r023) 2003; 16
Roshanali, F, Mandegar, MH, Yousefnia, MA, Alaeddini, F, Wann, S (r017) 2006; 23
Izumi, S, Miyatake, K, Beppu, S (r007) 1987; 76
Aklog, L, Filsoufi, F, Flores, KQ (r026) 2001; 104
White, HD, Norris, RM, Brown, MA, Brandt, PW, Whitlock, RM, Wild, CJ (r038) 1987; 76
Go, AS, Mozaffarian, D, Roger, VL (r001) 2014; 129
Christenson, JT, Simonet, F, Bloch, A, Maurice, J, Velebit, V, Schmuziger, M (r015) 1995; 4
Schroder, JN, Williams, ML, Hata, JA (r012) 2005; 112
Grigioni, F, Detaint, D, Avierinos, JF, Scott, C, Tajik, J, Enriquez-Sarano, M (r006) 2005; 45
Kang, DH, Kim, MJ, Kang, SJ (r028) 2006; 114
r020
Schroder JN (r012) 2005; 112
r021
r022
r001
r023
r040
r041
r017
r039
r018
r019
r013
r035
r014
r036
r037
r016
r038
Christenson JT (r015) 1995; 4
r031
r010
r032
r011
r033
r034
r030
r006
r028
r007
r029
r008
r009
r002
r024
r003
r025
r004
r026
r005
r027
22070836 - J Am Coll Cardiol. 2011 Dec 6;58(24):e123-210
23136163 - Circulation. 2012 Nov 20;126(21):2502-10
9264489 - Circulation. 1997 Aug 5;96(3):827-33
16820626 - Circulation. 2006 Jul 4;114(1 Suppl):I499-503
24352519 - Circulation. 2014 Jan 21;129(3):e28-e292
21352979 - Ann Thorac Surg. 2011 Mar;91(3):677-84; discussion p 684
23111018 - J Thorac Cardiovasc Surg. 2013 Nov;146(5):1139-1145.e6
19619766 - J Thorac Cardiovasc Surg. 2009 Aug;138(2):278-85
1452934 - J Am Coll Cardiol. 1992 Dec;20(7):1594-8
24744275 - Circulation. 2014 Jun 17;129(24):2547-56
25923566 - N Engl J Med. 2015 Apr 30;372(18):1770
19379967 - J Thorac Cardiovasc Surg. 2009 May;137(5):1063-70.e2
20868812 - Ann Thorac Surg. 2010 Oct;90(4):1187-94
22553307 - Circulation. 2012 May 29;125(21):2639-48
3652421 - Circulation. 1987 Oct;76(4):777-85
3594774 - Circulation. 1987 Jul;76(1):44-51
15919280 - Ann Thorac Surg. 2005 Jun;79(6):1895-901
11568033 - Circulation. 2001 Sep 18;104(12 Suppl 1):I68-75
12538997 - J Thorac Cardiovasc Surg. 2003 Jan;125(1):135-43
25923565 - N Engl J Med. 2015 Apr 30;372(18):1773-4
12815565 - J Card Fail. 2003 Jun;9(3):164-71
25405391 - N Engl J Med. 2014 Dec 4;371(23):2228-9
11463544 - Eur J Cardiothorac Surg. 2001 Aug;20(2):276-81
16159834 - Circulation. 2005 Aug 30;112(9 Suppl):I293-8
497341 - Biometrics. 1979 Sep;35(3):549-56
25923569 - N Engl J Med. 2015 Apr 30;372(18):1771
18721554 - Ann Thorac Surg. 2008 Sep;86(3):735-44
15364847 - Circulation. 2004 Sep 14;110(11 Suppl 1):II103-8
21788032 - J Thorac Cardiovasc Surg. 2012 Jan;143(1):111-7, 117.e1
15001891 - J Thorac Cardiovasc Surg. 2004 Mar;127(3):636-44
8581190 - J Heart Valve Dis. 1995 Sep;4(5):484-8; discussion 488-9
16412180 - Echocardiography. 2006 Jan;23(1):31-7
24603191 - J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185
22248680 - J Thorac Cardiovasc Surg. 2012 Feb;143(2):273-81
17971401 - Eur Heart J. 2007 Dec;28(23):2866-72
19786637 - Circulation. 2009 Oct 13;120(15):1474-81
16039207 - Ann Thorac Surg. 2005 Aug;80(2):570-7
10993859 - Circulation. 2000 Sep 19;102(12):1400-6
25923567 - N Engl J Med. 2015 Apr 30;372(18):1770
14583894 - J Card Fail. 2003 Oct;9(5):350-3
15680815 - Ann Thorac Surg. 2005 Feb;79(2):462-70; discussion 462-70
15653025 - J Am Coll Cardiol. 2005 Jan 18;45(2):260-7
25923570 - N Engl J Med. 2015 Apr 30;372(18):1771-3
26086049 - Rev Port Cardiol. 2015 Apr;34(4):305-7
25923568 - N Engl J Med. 2015 Apr 30;372(18):1770-1
12835667 - J Am Soc Echocardiogr. 2003 Jul;16(7):777-802
15655133 - Circulation. 2005 Jan 25;111(3):295-301
19723701 - N Engl J Med. 2009 Oct 1;361(14):1329-38
References_xml – volume: 125
  start-page: 135
  year: 2003
  end-page: 143
  ident: r010
  article-title: Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction.
  publication-title: J Thorac Cardiovasc Surg
– volume: 28
  start-page: 2866
  year: 2007
  end-page: 2872
  ident: r003
  article-title: Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure.
  publication-title: Eur Heart J
– volume: 90
  start-page: 1187
  year: 2010
  end-page: 1194
  ident: r013
  article-title: Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting.
  publication-title: Ann Thorac Surg
– volume: 35
  start-page: 549
  year: 1979
  end-page: 556
  ident: r024
  article-title: A multiple testing procedure for clinical trials.
  publication-title: Biometrics
– volume: 129
  start-page: e28
  year: 2014
  end-page: e292
  ident: r001
  article-title: Heart disease and stroke statistics -- 2014 update: a report from the American Heart Association.
  publication-title: Circulation
– volume: 45
  start-page: 260
  year: 2005
  end-page: 267
  ident: r006
  article-title: Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction.
  publication-title: J Am Coll Cardiol
– volume: 127
  start-page: 636
  year: 2004
  end-page: 644
  ident: r014
  article-title: Late outcomes in patients with uncorrected mild to moderate mitral regurgitation at the time of isolated coronary artery bypass grafting.
  publication-title: J Thorac Cardiovasc Surg
– volume: 137
  start-page: 1063
  year: 2009
  end-page: 1070
  ident: r018
  article-title: Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: a pilot cardiovascular magnetic resonance imaging study.
  publication-title: J Thorac Cardiovasc Surg
– volume: 120
  start-page: 1474
  year: 2009
  end-page: 1481
  ident: r016
  article-title: Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery.
  publication-title: Circulation
– volume: 76
  start-page: 44
  year: 1987
  end-page: 51
  ident: r038
  article-title: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
  publication-title: Circulation
– volume: 111
  start-page: 295
  year: 2005
  end-page: 301
  ident: r002
  article-title: Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation.
  publication-title: Circulation
– volume: 91
  start-page: 677
  year: 2011
  end-page: 684
  ident: r021
  article-title: Fifteen-year outcome trends for valve surgery in North America.
  publication-title: Ann Thorac Surg
– volume: 143
  start-page: 111
  year: 2012
  end-page: 117
  ident: r022
  article-title: Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network.
  publication-title: J Thorac Cardiovasc Surg
– volume: 112
  start-page: I
  year: 2005
  end-page: 293
  ident: r012
  article-title: Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. ;:Suppl
  publication-title: Circulation
– volume: 129
  start-page: 2547
  year: 2014
  end-page: 2556
  ident: r005
  article-title: Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience.
  publication-title: Circulation
– volume: 125
  start-page: 2639
  year: 2012
  end-page: 2648
  ident: r027
  article-title: Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial.
  publication-title: Circulation
– volume: 63
  start-page: e57
  year: 2014
  end-page: e185
  ident: r034
  article-title: 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
  publication-title: J Am Coll Cardiol ;[Erratum, J Am Coll Cardiol 2014;63:2489.]
– volume: 79
  start-page: 1895
  year: 2005
  end-page: 1901
  ident: r032
  article-title: Ischemic mitral regurgitation: revascularization alone versus revascularization and mitral valve repair.
  publication-title: Ann Thorac Surg
– volume: 96
  start-page: 827
  year: 1997
  end-page: 833
  ident: r004
  article-title: Clinical significance of mitral regurgitation after acute myocardial infarction.
  publication-title: Circulation
– volume: 9
  start-page: 164
  year: 2003
  end-page: 171
  ident: r040
  article-title: Effect of valsartan on hospitalization: results from Val-HeFT.
  publication-title: J Card Fail
– volume: 20
  start-page: 1594
  year: 1992
  end-page: 1598
  ident: r008
  article-title: Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure.
  publication-title: J Am Coll Cardiol
– volume: 23
  start-page: 31
  year: 2006
  end-page: 37
  ident: r017
  article-title: Low-dose dobutamine stress echocardiography to predict reversibility of mitral regurgitation with CABG.
  publication-title: Echocardiography
– volume: 104
  start-page: I
  year: 2001
  end-page: 68
  ident: r026
  article-title: Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? ;:Suppl 1
  publication-title: Circulation
– volume: 16
  start-page: 777
  year: 2003
  end-page: 802
  ident: r023
  article-title: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.
  publication-title: J Am Soc Echocardiogr
– volume: 9
  start-page: 350
  year: 2003
  end-page: 353
  ident: r039
  article-title: Ventricular remodeling in heart failure: a credible surrogate endpoint.
  publication-title: J Card Fail
– volume: 70
  start-page: 659
  year: 1983
  end-page: 663
  ident: r025
  article-title: Discrete sequential boundaries for clinical trials.
  publication-title: Biometrika
– volume: 58
  start-page: e123
  year: 2011
  end-page: e210
  ident: r033
  article-title: 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons.
  publication-title: J Am Coll Cardiol
– volume: 76
  start-page: 777
  year: 1987
  end-page: 785
  ident: r007
  article-title: Mechanism of mitral regurgitation in patients with myocardial infarction: a study using real-time two-dimensional Doppler flow imaging and echocardiography.
  publication-title: Circulation
– volume: 79
  start-page: 462
  year: 2005
  end-page: 470
  ident: r011
  article-title: Importance of moderate ischemic mitral regurgitation.
  publication-title: Ann Thorac Surg
– volume: 80
  start-page: 570
  year: 2005
  end-page: 577
  ident: r031
  article-title: Long-term survival after surgical revascularization for moderate ischemic mitral regurgitation.
  publication-title: Ann Thorac Surg
– volume: 126
  start-page: 2502
  year: 2012
  end-page: 2510
  ident: r037
  article-title: Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial.
  publication-title: Circulation
– volume: 102
  start-page: 1400
  year: 2000
  end-page: 1406
  ident: r009
  article-title: Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study.
  publication-title: Circulation
– volume: 146
  start-page: 1139
  year: 2013
  end-page: 1145
  ident: r035
  article-title: Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction.
  publication-title: J Thorac Cardiovasc Surg
– volume: 4
  start-page: 484
  year: 1995
  end-page: 488
  ident: r015
  article-title: Should a mild to moderate ischemic mitral valve regurgitation in patients with poor left ventricular function be repaired or not?
  publication-title: J Heart Valve Dis
– volume: 20
  start-page: 276
  year: 2001
  end-page: 281
  ident: r030
  article-title: The importance of grade 2 ischemic mitral regurgitation in coronary artery bypass grafting.
  publication-title: Eur J Cardiothorac Surg
– volume: 143
  start-page: 273
  year: 2012
  end-page: 281
  ident: r020
  article-title: Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database.
  publication-title: J Thorac Cardiovasc Surg
– volume: 114
  start-page: I
  year: 2006
  end-page: 499
  ident: r028
  article-title: Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. ;:Suppl
  publication-title: Circulation
– volume: 110
  start-page: II
  year: 2004
  end-page: 103
  ident: r019
  article-title: Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. ;:Suppl
  publication-title: Circulation
– volume: 361
  start-page: 1329
  year: 2009
  end-page: 1338
  ident: r041
  article-title: Cardiac-resynchronization therapy for the prevention of heart-failure events.
  publication-title: N Engl J Med
– volume: 86
  start-page: 735
  year: 2008
  end-page: 744
  ident: r029
  article-title: Survival prognosis and surgical management of ischemic mitral regurgitation.
  publication-title: Ann Thorac Surg
– volume: 138
  start-page: 278
  year: 2009
  end-page: 285
  ident: r036
  article-title: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial.
  publication-title: J Thorac Cardiovasc Surg
– ident: r037
  doi: 10.1161/CIRCULATIONAHA.112.143818
– ident: r004
  doi: 10.1161/01.CIR.96.3.827
– ident: r035
  doi: 10.1016/j.jtcvs.2012.09.007
– ident: r014
  doi: 10.1016/j.jtcvs.2003.09.010
– ident: r016
  doi: 10.1161/CIRCULATIONAHA.108.842104
– ident: r027
  doi: 10.1161/CIRCULATIONAHA.111.072256
– ident: r001
  doi: 10.1161/01.cir.0000441139.02102.80
– ident: r041
  doi: 10.1056/NEJMoa0906431
– ident: r005
  doi: 10.1161/CIRCULATIONAHA.113.005223
– ident: r029
  doi: 10.1016/j.athoracsur.2008.05.017
– ident: r036
  doi: 10.1016/j.jtcvs.2008.11.010
– ident: r038
  doi: 10.1161/01.CIR.76.1.44
– ident: r003
  doi: 10.1093/eurheartj/ehm469
– ident: r008
  doi: 10.1016/0735-1097(92)90455-V
– ident: r034
  doi: 10.1016/j.jacc.2014.02.536
– ident: r007
  doi: 10.1161/01.CIR.76.4.777
– volume: 112
  start-page: I
  year: 2005
  ident: r012
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.523472
– ident: r018
  doi: 10.1016/j.jtcvs.2008.12.023
– ident: r033
  doi: 10.1016/j.jacc.2011.08.009
– ident: r013
  doi: 10.1016/j.athoracsur.2010.03.103
– ident: r021
  doi: 10.1016/j.athoracsur.2010.11.009
– ident: r040
  doi: 10.1054/jcaf.2003.22
– ident: r017
  doi: 10.1111/j.1540-8175.2006.00163.x
– ident: r011
  doi: 10.1016/j.athoracsur.2004.07.040
– ident: r002
  doi: 10.1161/01.CIR.0000151097.30779.04
– ident: r022
  doi: 10.1016/j.jtcvs.2011.05.006
– ident: r032
  doi: 10.1016/j.athoracsur.2004.11.005
– ident: r020
  doi: 10.1016/j.jtcvs.2011.10.029
– ident: r030
  doi: 10.1016/S1010-7940(01)00770-9
– ident: r019
  doi: 10.1161/01.CIR.0000138196.06772.4e
– ident: r010
  doi: 10.1067/mtc.2003.78
– volume: 4
  start-page: 484
  year: 1995
  ident: r015
  publication-title: J Heart Valve Dis
– ident: r025
  doi: 10.2307/2336502
– ident: r039
  doi: 10.1054/j.cardfail.2003.09.001
– ident: r023
  doi: 10.1016/S0894-7317(03)00335-3
– ident: r031
  doi: 10.1016/j.athoracsur.2005.03.034
– ident: r009
  doi: 10.1161/01.CIR.102.12.1400
– ident: r026
  doi: 10.1161/hc37t1.094706
– ident: r006
  doi: 10.1016/j.jacc.2004.10.030
– ident: r024
  doi: 10.2307/2530245
– ident: r028
  doi: 10.1161/CIRCULATIONAHA.105.000398
– reference: 21352979 - Ann Thorac Surg. 2011 Mar;91(3):677-84; discussion p 684
– reference: 3594774 - Circulation. 1987 Jul;76(1):44-51
– reference: 19379967 - J Thorac Cardiovasc Surg. 2009 May;137(5):1063-70.e2
– reference: 25405391 - N Engl J Med. 2014 Dec 4;371(23):2228-9
– reference: 25923566 - N Engl J Med. 2015 Apr 30;372(18):1770
– reference: 19723701 - N Engl J Med. 2009 Oct 1;361(14):1329-38
– reference: 8581190 - J Heart Valve Dis. 1995 Sep;4(5):484-8; discussion 488-9
– reference: 15680815 - Ann Thorac Surg. 2005 Feb;79(2):462-70; discussion 462-70
– reference: 18721554 - Ann Thorac Surg. 2008 Sep;86(3):735-44
– reference: 19786637 - Circulation. 2009 Oct 13;120(15):1474-81
– reference: 22070836 - J Am Coll Cardiol. 2011 Dec 6;58(24):e123-210
– reference: 15364847 - Circulation. 2004 Sep 14;110(11 Suppl 1):II103-8
– reference: 1452934 - J Am Coll Cardiol. 1992 Dec;20(7):1594-8
– reference: 20868812 - Ann Thorac Surg. 2010 Oct;90(4):1187-94
– reference: 22248680 - J Thorac Cardiovasc Surg. 2012 Feb;143(2):273-81
– reference: 25923569 - N Engl J Med. 2015 Apr 30;372(18):1771
– reference: 15919280 - Ann Thorac Surg. 2005 Jun;79(6):1895-901
– reference: 26086049 - Rev Port Cardiol. 2015 Apr;34(4):305-7
– reference: 17971401 - Eur Heart J. 2007 Dec;28(23):2866-72
– reference: 24603191 - J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185
– reference: 25923565 - N Engl J Med. 2015 Apr 30;372(18):1773-4
– reference: 11463544 - Eur J Cardiothorac Surg. 2001 Aug;20(2):276-81
– reference: 23136163 - Circulation. 2012 Nov 20;126(21):2502-10
– reference: 16820626 - Circulation. 2006 Jul 4;114(1 Suppl):I499-503
– reference: 22553307 - Circulation. 2012 May 29;125(21):2639-48
– reference: 3652421 - Circulation. 1987 Oct;76(4):777-85
– reference: 16039207 - Ann Thorac Surg. 2005 Aug;80(2):570-7
– reference: 16159834 - Circulation. 2005 Aug 30;112(9 Suppl):I293-8
– reference: 14583894 - J Card Fail. 2003 Oct;9(5):350-3
– reference: 15655133 - Circulation. 2005 Jan 25;111(3):295-301
– reference: 24352519 - Circulation. 2014 Jan 21;129(3):e28-e292
– reference: 25923570 - N Engl J Med. 2015 Apr 30;372(18):1771-3
– reference: 15001891 - J Thorac Cardiovasc Surg. 2004 Mar;127(3):636-44
– reference: 19619766 - J Thorac Cardiovasc Surg. 2009 Aug;138(2):278-85
– reference: 12538997 - J Thorac Cardiovasc Surg. 2003 Jan;125(1):135-43
– reference: 15653025 - J Am Coll Cardiol. 2005 Jan 18;45(2):260-7
– reference: 25923567 - N Engl J Med. 2015 Apr 30;372(18):1770
– reference: 12835667 - J Am Soc Echocardiogr. 2003 Jul;16(7):777-802
– reference: 10993859 - Circulation. 2000 Sep 19;102(12):1400-6
– reference: 497341 - Biometrics. 1979 Sep;35(3):549-56
– reference: 11568033 - Circulation. 2001 Sep 18;104(12 Suppl 1):I68-75
– reference: 24744275 - Circulation. 2014 Jun 17;129(24):2547-56
– reference: 23111018 - J Thorac Cardiovasc Surg. 2013 Nov;146(5):1139-1145.e6
– reference: 21788032 - J Thorac Cardiovasc Surg. 2012 Jan;143(1):111-7, 117.e1
– reference: 12815565 - J Card Fail. 2003 Jun;9(3):164-71
– reference: 25923568 - N Engl J Med. 2015 Apr 30;372(18):1770-1
– reference: 9264489 - Circulation. 1997 Aug 5;96(3):827-33
– reference: 16412180 - Echocardiography. 2006 Jan;23(1):31-7
SSID ssj0000149
Score 2.6052263
Snippet This trial compared coronary-artery bypass grafting alone with CABG plus mitral-valve repair in patients with coronary artery disease and moderate ischemic...
Ischemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding...
BackgroundIschemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
mms
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2178
SubjectTerms Aged
Biological and medical sciences
Cardiology. Vascular system
Cardiovascular disease
Cardiovascular Diseases - etiology
Cardiovascular Diseases - mortality
Cerebrovascular system
Coronary artery
Coronary Artery Bypass
Coronary vessels
Endocardial and cardiac valvular diseases
Female
General aspects
Heart
Heart surgery
Humans
Ischemia
Male
Medical sciences
Middle Aged
Mitral Valve Insufficiency - etiology
Mitral Valve Insufficiency - surgery
Morbidity
Myocardial Ischemia - complications
Myocardial Ischemia - surgery
Patients
Postoperative Complications - epidemiology
Quality of Life
Regurgitation
Ventricle
Ventricular Remodeling
Title Surgical Treatment of Moderate Ischemic Mitral Regurgitation
URI https://nejm.org/doi/full/10.1056/NEJMoa1410490
https://www.ncbi.nlm.nih.gov/pubmed/25405390
https://www.proquest.com/docview/1630543268
https://www.proquest.com/docview/1634280977
https://pubmed.ncbi.nlm.nih.gov/PMC4303577
Volume 371
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS-NAEB-swuHLoZ6nObVEEJ8Mmma_AoKoKCpUDj-gb2Gz2fWDa-LZ9v93JtnWVtSXvOxkE3Y-9jc7szMAO9oyVRjBI6osEjFhTaRjfKjYcuvSQglGF5y71-Linl31eM8fuA18WuXYJtaGuqgMnZHvI25AdIFgQx29_I-oaxRFV30LjRYs0B1Qcr7UaTxVPsrDX3-C5Gts4p6_T53mK01JjozM8dSe1Or3B5QhqQe4SK7pbvEZ_PyYRTm1LZ0vwU-PJ8PjRgCWYc6WK_Cj6yPmv-DwdvRaG7fwbpxSHlYurFugIcwML9G7pfz4sPtE04c39oFeaAL0q3B_fnZ3ehH5jgmRYZIPo5jnuWCx0kI7VGV7QP6QkSpGDG07KUKnXBWxMknRSUzCUPdMohOrqWaLkXGR_Ib5sirtOoQIGxKH4KQjCs6KjkilcU5Lx1OVG-nSAPbGa5YZ_1fU1eJfVoe1uchmljiA3Qn5S1NH4yvCNjIgK-1z_0uCGd5MpkPXkeCHCmBzzKzMK-QgexefALYnw6hKFB_Rpa1GNQ06YyhGMoC1hrfvkxOyTejrcobrEwIq0z07Uj491uW6GaIELuWf739rAxYRi9U1JA_YJswPX0d2C_HOMG9DS_ZkuxbtNiycnF3_vXkDZBv9zg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ3db9MwEMBPWycBL4hvso1hJOCJaE3iOI7EhPjY1LK1QqOT9pY5jg1DazLWVhP_HH8bd4nTtYjxtpe85OJEvov9O_t8B_BSGS4LLWKfMov4XBjtqwAvMjCxsWkhBacDzoOh6B3xz8fx8Qr8bs_CUFhlOybWA3VRaVoj30ZuQLpA2JDvzn_6VDWKdlfbEhrKlVYoduoUY-5gx775dYku3GSn_wn1_SoM93ZHH3u-qzLga57EUz-I81zwQCqhLJq_6ZIPoRMZIHeaMEXcyGURSB0VYaQjjvaqIxUZRXlOdBIUEba7CmucFlA6sPZhd_jlcCGBlQNwt4blsnwidWxTrftKUZglpwlhYVZcHY8nFKOpJqgm29TX-BcA_x3HuTAx7t2Du45o2fvGBO_DiikfwK2B27N_CG-_zi7q4ZWN2qB2VllWF2FD0GV99K8pQp8NTql5dmi-0QNNiMAjOLqR3nwMnbIqzVNgCC6RRTwKRRHzIhRpoq1ViY1TmevEph68afss0-6rqK7GWVZvrMciW-piD17Pxc-bTB7XCW6hArLS_BhfK7Ckm3lz6LwSAEkPNltlZW5ImGRXBuzBi_lt_Jlph0aVpprVMugOdpHJPXjS6PaqcWLriN6eLGl9LkCJwpfvlKff64ThHDklTpL1_3_Wc7jdGw0OsoP-cH8D7iAZ1hktu3wTOtOLmXmG9DXNt5yJMzi56b_qDzfpPO8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ1fb9MwEMBP25AmXib-ExjDSMATUZvEjh2JCSFGtTI6IdikvgXHsccQTcbaCvHV9um4S5yuRYy3veQlFyfyne3f2Zc7gOfaclWaVISUWSTkqTWhjvCiIiusy0qVcvrBeXSY7h_zD2MxXoOL7l8YCqvs5sRmoi5rQ3vkPeQGpAuEDdVzPizi097gzdnPkCpI0UlrV06jNZED-_sXum_T3eEe6vpFHA_eH73bD32FgdBwKWZhJIoi5ZHSqXZo-rZP_oORKkLmtHGGqFGoMlImKePEJBxt1SQ6sZpynBgZlQm2uw43ZMI5lY2QY7mUusqjt9-98vk9kTd6VOW-1hRgyWkpWFoP1yeTKUVn6ikqyLWVNf6Fvn9HcC4tiYNbsOVZlr1tje82rNnqDmyO_Gn9XXj9ZX7eTKzsqAtnZ7VjTfk1RFw2RM-aYvPZ6JSaZ5_tCT3QBgfcg-Nr6cv7sFHVlX0IDJElcQhGcVoKXsZpJo1zWjqRqcJIlwXwquuz3PivoooaP_LmSF2k-UoXB_ByIX7W5vC4SnAHFZBX9vvkSoEV3SyaQ7eV0EcFsN0pK_eTwTS_NN0Ani1u4zCmsxld2XreyKAj2EcaD-BBq9vLxomqE3q7XNH6QoBShK_eqU6_NanCORKKkPLR_z_rKWziWMo_Dg8PHsNNRMImlWWfb8PG7HxunyB2zYqdxr4ZfL3uAfUHeXc6iw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Surgical+Treatment+of+Moderate+Ischemic+Mitral+Regurgitation&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Smith%2C+Peter+K.&rft.au=Puskas%2C+John+D.&rft.au=Ascheim%2C+Deborah+D.&rft.au=Voisine%2C+Pierre&rft.date=2014-12-04&rft.issn=0028-4793&rft.eissn=1533-4406&rft.volume=371&rft.issue=23&rft.spage=2178&rft.epage=2188&rft_id=info:doi/10.1056%2FNEJMoa1410490&rft.externalDBID=n%2Fa&rft.externalDocID=10_1056_NEJMoa1410490
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon